Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25271 | 238 | 35.3 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3119 | 1786 | CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROSTATE STEM CELL ANTIGEN | Author keyword | 42 | 72% | 14% | 33 |
2 | PROSTATE STEM CELL ANTIGEN PSCA | Author keyword | 22 | 81% | 5% | 13 |
3 | PSCA | Author keyword | 20 | 52% | 12% | 28 |
4 | PLCE1 | Author keyword | 16 | 64% | 7% | 16 |
5 | PHOSPHOLIPASE C EPSILON 1 | Author keyword | 4 | 67% | 2% | 4 |
6 | BASIC ONCOL PATHOL | Address | 3 | 100% | 1% | 3 |
7 | GASTROENTEROL THORAC SURG | Address | 3 | 100% | 1% | 3 |
8 | HLTH SCREENING ENDOSCOPY | Address | 3 | 100% | 1% | 3 |
9 | INTERNAL MONGOLIA MED | Address | 3 | 100% | 1% | 3 |
10 | THORAC SURG RADIOTHER Y | Address | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTATE STEM CELL ANTIGEN | 42 | 72% | 14% | 33 | Search PROSTATE+STEM+CELL+ANTIGEN | Search PROSTATE+STEM+CELL+ANTIGEN |
2 | PROSTATE STEM CELL ANTIGEN PSCA | 22 | 81% | 5% | 13 | Search PROSTATE+STEM+CELL+ANTIGEN+PSCA | Search PROSTATE+STEM+CELL+ANTIGEN+PSCA |
3 | PSCA | 20 | 52% | 12% | 28 | Search PSCA | Search PSCA |
4 | PLCE1 | 16 | 64% | 7% | 16 | Search PLCE1 | Search PLCE1 |
5 | PHOSPHOLIPASE C EPSILON 1 | 4 | 67% | 2% | 4 | Search PHOSPHOLIPASE+C+EPSILON+1 | Search PHOSPHOLIPASE+C+EPSILON+1 |
6 | RS2294008 | 2 | 67% | 1% | 2 | Search RS2294008 | Search RS2294008 |
7 | 10Q23 | 1 | 38% | 1% | 3 | Search 10Q23 | Search 10Q23 |
8 | 1Q22 | 1 | 50% | 1% | 2 | Search 1Q22 | Search 1Q22 |
9 | PLCE1 RS2274223 | 1 | 100% | 1% | 2 | Search PLCE1+RS2274223 | Search PLCE1+RS2274223 |
10 | FAD24 | 1 | 40% | 1% | 2 | Search FAD24 | Search FAD24 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PSCA | 59 | 81% | 15% | 35 |
2 | PLCE1 | 24 | 61% | 11% | 25 |
3 | PSCA EXPRESSION | 21 | 90% | 4% | 9 |
4 | C20ORF54 | 17 | 79% | 5% | 11 |
5 | STEM CELL ANTIGEN | 16 | 26% | 22% | 52 |
6 | 10Q23 | 11 | 50% | 7% | 16 |
7 | UPPER GASTROINTESTINAL CANCERS | 10 | 73% | 3% | 8 |
8 | PHOSPHOLIPASE C EPSILON | 5 | 21% | 10% | 23 |
9 | FAD24 | 3 | 100% | 1% | 3 |
10 | PSCA GENE | 3 | 100% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study | 2013 | 30 | 54 | 50% |
Association of a common genetic variant in prostate stem cell antigen with cancer risk | 2014 | 2 | 36 | 69% |
Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications | 2014 | 2 | 72 | 67% |
Genetics of gastric cancer | 2014 | 13 | 149 | 14% |
Prostate Stem Cell Antigen Polymorphisms and Susceptibility to Gastric Cancer: A Systematic Review and Meta-analysis | 2012 | 10 | 41 | 51% |
Mucin 1 Gene (MUC1) and Gastric-Cancer Susceptibility | 2014 | 4 | 69 | 25% |
Prostate stem cell antigen: A prospective therapeutic and diagnostic target | 2009 | 37 | 48 | 40% |
Gastric cancer-molecular and clinical dimensions | 2013 | 38 | 179 | 7% |
Evolution of the concept of androgen-sensitive bladder cancer | 2013 | 1 | 23 | 35% |
Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications | 2009 | 18 | 46 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BASIC ONCOL PATHOL | 3 | 100% | 1.3% | 3 |
2 | GASTROENTEROL THORAC SURG | 3 | 100% | 1.3% | 3 |
3 | HLTH SCREENING ENDOSCOPY | 3 | 100% | 1.3% | 3 |
4 | INTERNAL MONGOLIA MED | 3 | 100% | 1.3% | 3 |
5 | THORAC SURG RADIOTHER Y | 3 | 100% | 1.3% | 3 |
6 | HLTH SCI 66 134 | 2 | 67% | 0.8% | 2 |
7 | MED MED MANAGEMENT | 2 | 67% | 0.8% | 2 |
8 | BEIJING BIOTECHNOL | 2 | 50% | 1.3% | 3 |
9 | PROFESS STUDY | 2 | 50% | 1.3% | 3 |
10 | PATHOL THORAC SURG | 1 | 38% | 1.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200450 | STEAP4//STAMP2//STEAP |
2 | 0.0000197019 | MAL DE MELEDA//TEX101//SLURP 1 |
3 | 0.0000124100 | HIGH INCIDENCE AREA//HEBEI TUMOR HOSP//GOLESTAN GASTROENTEROL HEPATOL |
4 | 0.0000121640 | PHOSPHOLIPASE C DELTA 1//PHOSPHOLIPASE C GAMMA 1//GENOME BIOSIGNAL |
5 | 0.0000096244 | NORPEG//N COPINE//PSGR |
6 | 0.0000088483 | RNASEL//HEREDITARY PROSTATE CANCER//8Q24 |
7 | 0.0000087485 | CASP10//CASP8//CASPASE 10 |
8 | 0.0000087077 | GPRC5A//GNAS1//CELLULAR SIGNALINGCANC |
9 | 0.0000085225 | WHO ABORAT FOOD NUTR POLICIES//STUDIES MED PROGRAMS SERV//COMPLEX GENET |
10 | 0.0000081789 | CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE |